[breadcrumb_custom]

Tag: Gilead Sciences Inc.

Companies

Gilead Sciences Inc. (NASDAQ:GILD): The Fundamentals Have Changed

Gilead Sciences Inc. (NASDAQ:GILD) previous close was $68.77 while the outstanding shares total 1.26B. The firm has a beta of 0.39, a 12-month trailing P/E

Companies

Are Gilead Sciences Inc. (NASDAQ:GILD) Prospects Worsening?

Gilead Sciences Inc. (NASDAQ:GILD) has a beta of 0.39, a 12-month trailing P/E ratio of 327.28, and a growth ratio of 110.01. The stock’s Relative

Finance

Gilead Sciences Inc. (GILD) is down -8.76% from 52 weeks low but Don’t Get Your Hopes high

Gilead Sciences Inc. (NASDAQ:GILD) previous close was $66.11 while the outstanding shares total 1.26B. The firm has a beta of 0.40, a 12-month trailing P/E

Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.

Quick Links

About Us

Our Team

Disclaimer

Tag: Gilead Sciences Inc.

Gilead Sciences Inc. (NASDAQ:GILD): The Fundamentals Have Changed

Are Gilead Sciences Inc. (NASDAQ:GILD) Prospects Worsening?

Gilead Sciences Inc. (GILD) is down -8.76% from 52 weeks low but Don’t Get Your Hopes high

Quick Links

Categories